Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: acute coronary + patients with + outcomes  Related to the article below (Last Update: 5/13/2008)

Study: Heart attacks difficult to detect in women
Sun-Sentinel.com, FL -
In all, among patients with the same level of coronary artery disease, women were significantly less likely than men to receive drugs called beta blockers, ...
Lipid Sciences, Inc. Reports Financial Results for the First ...
CNNMoney.com -
Regression of such plaques may have a major impact on reducing the risk of acute coronary events. The Company's Viral Immunotherapy platform focuses on the ...LIPD
Cardium Reports on First Quarter 2008 Highlights and Financial Results
FOXBusiness - May 10, 2008
Dr. Schatz is a pioneer of coronary stent technology and is Research Director of Cardiovascular Interventions at the Heart, Lung, and Vascular Center at ...CXM

AFP
India overwhelmed by heart disease: study
AFP - Apr 24, 2008
"This registry is a major milestone, since it provides the first comprehensive view of the epidemic of acute coronary syndrome in India and helps to ...
Lipid Sciences Broadens Intellectual Property Portfolio With Two ...
PharmaLive.com (press release), PA - May 7, 2008
Regression of such plaques may have a major impact on reducing the risk of acute coronary events. The Company's Viral Immunotherapy platform focuses on the ...LIPD
Edwards Lifesciences Introduces New Transcatheter Valve Delivery ...
Earthtimes (press release), UK -
His presentation, "Percutaneous mitral valve repair: coronary sinus annuloplasty," will take place during the session, "Patients with mitral regurgitation: ...EW
Precipitating Factors" Influence Heart Failure Outcomes
Medscape (subscription) - May 1, 2008
Specific precipitants of exacerbation of heart failure examined in the current study included ischemia/acute coronary syndrome, uncontrolled hypertension, ...
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for ...
Earthtimes (press release), UK - May 8, 2008
FLECTOR(R) Patch has been available since January in the United States for the topical treatment of acute pain due to minor strains, sprains and contusions. ...ALO
Cardium Reports on First Quarter 2008 Highlights and Financial Results
MSN Money - May 9, 2008
Dr. Schatz is a pioneer of coronary stent technology and is Research Director of Cardiovascular Interventions at the Heart, Lung, and Vascular Center at ...CXM
Growth Differentiation Factor-15 for Prognostic Assessment of ...
RedOrbit, TX - May 2, 2008
Circulating levels of GDF-15 provide independent prognostic information in patients with acute coronary syndromes or heart failure. ...
Source: Google News

… of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe … -
D Hasdai, S Behar, L Wallentin, N Danchin, AK Gitt … - European Heart Journal, 2002 - Eur Soc Cardiology
... A prospective survey of the characteristics, treatments and outcomes of patients
with acute coronary syndromes in Europe and the Mediterranean basin. ...

Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes -
JS Hochman, JE Tamis, TD Thompson, WD Weaver, HD … - New England Journal of Medicine, 1999 - content.nejm.org
... Gender differences in management and outcomes in patients with acute coronary syndromes:
results on 20 290 patients from the AMIS Plus Registry. ...

Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment … -
E Boersma, KS Pieper, EW Steyerberg, RG Wilcox, WC … - Circulation, 2000 - Am Heart Assoc
... Early percutaneous coronary intervention, platelet inhibition with eptifibatide,
and clinical outcomes in patients with acute coronary syndromes. Circulation.. ...

… Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute … -
PB Berger, SG Ellis, DR Holmes, CB Granger, DA … - Circulation, 1999 - Am Heart Assoc
... Relationship Between Delay in Performing Direct Coronary Angioplasty and Early
Clinical Outcome in Patients With Acute Myocardial Infarction. ...

… outcomes of patients hospitalized with acute coronary syndromes in the global registry of acute … -
PG Steg, RJ Goldberg, JM Gore - ACC Current Journal Review, 2002 - Elsevier
... Baseline characteristics, management practices, and in-hospital outcomes of patients
hospitalized with acute coronary syndromes in the global registry of acute ...

Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes -
SV Rao, JG Jollis, RA Harrington, CB Granger, LK … - JAMA, 2004 - Am Med Assoc
... Relationship of Blood Transfusion and Clinical Outcomes in Patients With
Acute Coronary Syndromes Sunil V. Rao, MD ; James G. Jollis ...

… blocker abciximab on outcome in patients with acute coronary syndromes without early coronary … -
ML Simoons - Lancet, 2001 - journals.indexcopernicus.com
... Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients
with acute coronary syndromes without early coronary revascularisation: the ...

… after sirolimus-eluting stent implantation in patients with acute coronary syndromes Insights from … -
PA Lemos, C Lee, M Degertekin, F Saia, K Tanabe, … - Journal of the American College of Cardiology, 2003 - Am Coll Cardio Found
... OBJECTIVES: This study evaluated the early outcomes of patients with acute coronary
syndromes (ACS) treated with sirolimus-eluting stents (SES). ...

… syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary … -
KAA Fox, SG Goodman, W Klein, D Brieger, PG Steg, … - European Heart Journal, 2002 - Eur Soc Cardiology
... and in highly selected populations of patients, and hence ... in hospital management
and outcome using unselected ... Global Registry of Acute Coronary Events (GRACE). ...

… Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary … -
JA de Lemos, DA Morrow, MS Sabatine, SA Murphy, CM … - Circulation, 2003 - Am Heart Assoc
... Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and
Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes. ...

Source: Google Scholar

Similar Outcomes After One Year For Patients With Acute Coronary Syndromes Treated With Different Anticoagulant Regimens

Patients with acute coronary syndromes such as unstable angina who were undergoing an invasive treatment and received one of three anticoagulant regimens did not have significant differences in the rates of ischemia or death after one year, according to a study in the December 5 issue of JAMA.

“Early angiography followed by interventional or surgical revascularization when appropriate has been shown to result in reduced rates of death, myocardial infarction (MI), refractory ischemia, and rehospitalization in patients with acute coronary syndromes (ACS; unstable angina or non–ST-segment elevation MI [a certain pattern on an electrocardiogram following a heart attack]). Because both MI and hemorrhagic complications have been associated with early and late mortality in patients with ACS and in those undergoing percutaneous coronary intervention (PCI), the optimal [added] pharmacological regimen to support the invasive approach in ACS would ideally suppress adverse ischemic and thrombotic events while minimizing iatrogenic [induced by treatment] bleeding,” the authors write.

In the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial, randomization of moderate-risk and high-risk patients with ACS undergoing early invasive management to monotherapy with the direct thrombin (blood-clotting enzyme) inhibitor bivalirudin compared with a heparin-based regimen plus glycoprotein (GP) IIb/IIIa inhibitors resulted in noninferior 30-day rates of adverse ischemic events with reduced rates of major bleeding. The long-term effect of bivalirudin monotherapy and a selective GP IIb/IIIa inhibitor strategy on composite ischemia and death are unknown.

Gregg W. Stone, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York, and colleagues examined the 1-year clinical outcomes of patients enrolled in the ACUITY trial. The randomized, open-label trial was conducted at 450 academic and community-based institutions in 17 countries. A total of 13,819 patients with moderate- and high-risk ACS undergoing invasive treatment were enrolled between August 2003 and December 2005. Patients were assigned to heparin plus GP IIb/IIIa inhibitors (n = 4,603), bivalirudin plus GP IIb/IIIa inhibitors (n = 4,604), or bivalirudin monotherapy (n = 4,612). Of these patients, 4,605 were assigned to routine upstream (prior to angiography) GP IIb/IIIa use and 4,602 were deferred to selective GP IIb/IIIa use.

Compared with the control group of heparin plus GP IIb/IIIa inhibitors in which the 1-year estimated rate of composite ischemia was 15.4 percent, composite ischemia occurred in 16.0 percent of patients assigned to bivalirudin plus GP IIb/IIIa inhibitors and in 16.2 percent of patients assigned to bivalirudin monotherapy. Death at 1 year occurred in an estimated 3.9 percent of patients assigned to heparin plus GP IIb/IIIa inhibitors, 3.9 percent assigned to bivalirudin plus GP IIb/IIIa inhibitors, and 3.8 percent assigned to bivalirudin monotherapy. There were no significant differences in the rates of the individual components of death, MI, or unplanned revascularization for ischemia between the three groups.

“At 1 year, no statistically significant difference in rates of composite ischemia or mortality among patients with moderate- and high-risk ACS undergoing invasive treatment with the 3 therapies was found,” the authors conclude. “There was no statistically significant difference in the rates of composite ischemia between patients receiving routine upstream administration of GP IIb/IIIa inhibitors vs. deferring their use for patients undergoing PCI.”

(JAMA. 2007;298(21):2497-2506. Available pre-embargo to the media at www.jamamedia.org)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.